OBJECTIVE—To study cross-sectional associations of dietary fiber intake with insulin resistance, insulin secretion, and glucose tolerance in a population at high risk for type 2 diabetes.

RESEARCH DESIGN AND METHODS—The subjects consisted of 248 male and 304 female adult nondiabetic relatives of patients with type 2 diabetes. Dietary intake was measured by means of two 3-day food records. Associations of total, water-insoluble, and water-soluble fiber with measures of glucose metabolism based on an oral glucose tolerance test, were analyzed by multiple linear regression analysis adjusting for sex, age, length of education, physical activity, BMI, waist-to-hip ratio, systolic blood pressure, and serum triglyceride and HDL cholesterol concentrations. The homeostasis model assessment insulin resistance index, the incremental 30-min serum insulin concentration divided by the incremental 30-min glucose concentration, and fasting and 2-h glucose concentrations were the outcome variables.

RESULTS—The dietary intake of total as well as water-insoluble and water-soluble fiber was inversely associated with insulin resistance: −0.17 (0.07), P = 0.012; −0.15 (0.07), P = 0.024; and −0.14 (0.07), P = 0.049 [regression coefficients (SE)]. Fiber variables were unrelated to insulin secretion and plasma glucose concentrations.

CONCLUSIONS—The results support evidence that a high intake of dietary fiber is associated with enhanced insulin sensitivity and therefore may have a role in the prevention of type 2 diabetes.

Diet is regarded as one of the environmental determinants of type 2 diabetes. A typical feature of the modern western lifestyle diet is a low fiber intake that has been implicated in several diseases of western civilization, including type 2 diabetes. Although experimental high-fiber diets have been associated with improved glucose metabolism (1,2), the results of epidemiological studies are inconsistent. Available data suggest a positive effect on insulin sensitivity (36), while association with glucose tolerance and diabetes risk has been more controversial (714).

The beneficial effect of dietary fiber has mainly been ascribed to the water-soluble fiber fraction, while the role of water-insoluble fiber has been regarded as less convincing (15,16). However, some recent prospective studies (13,14,17) suggest a protective role specific to water-insoluble dietary fiber against type 2 diabetes.

In the present cross-sectional study, we sought to determine whether habitual dietary fiber intake (total, water-insoluble, and water-soluble fiber) was related to insulin resistance, insulin secretion, or glucose concentrations in a population at high risk for type 2 diabetes.

The Botnia Dietary Study investigates relationships between diet and glucose metabolism in relatives of patients with type 2 diabetes. The study was conducted between October 1994 and June 1997 as part of the follow-up investigation of the Botnia Study, which is a prospective family study in western Finland aimed at the identification of genetic and metabolic defects in type 2 diabetes (18). The study was approved by the local ethics committees. The inclusion criteria for the dietary study were 1) a first- or second-degree family history of type 2 diabetes, 2) aged 20–70 years at the time of the baseline investigation, and 3) normal or impaired glucose tolerance according to the 1985 World Health Organization criteria (19) at baseline investigation. A consecutive sample of 746 subjects fulfilling the inclusion criteria was invited to participate. Accepted data on dietary intake were received from 590 (79%) of those invited. However, 17 subjects were excluded from the present analyses because of missing laboratory data, 14 subjects with newly diagnosed diabetes, and 7 subjects using fiber-containing laxatives. Among the remaining 552 subjects (comprising 74% of the invited subjects), the proportion of women willing to participate and included in the analyses (77%) was higher (P = 0.037) than that of men (71%). There was no difference in sex-adjusted mean age, BMI, waist-to-hip ratio, physical activity, or length of education between those who did and did not participate. However, in participants, a lower fasting plasma glucose concentration (5.4 vs. 5.6 mmol/l, P = 0.017), a lower 2-h plasma glucose concentration (5.8 vs. 6.5 mmol/l, P = 0.001), and a lower fasting serum insulin concentration (48 vs. 54 pmol/l, P = 0.016) were observed. Of the participants, 539 (98%) were first- and 13 (2%) were second-degree relatives of subjects with type 2 diabetes.

Food consumption in the Botnia Dietary Study was measured by means of two 3-day estimated food records kept ∼6 months (range 5–11) apart. Trained study nurses instructed the participants to record every item of food or drink consumed, in as much detail as possible, immediately after each eating episode. It was emphasized that it was very important not to change food habits, i.e., the amount or quality of the food or drink consumed during the study period, because of the record keeping. The record form also included detailed written instructions for record keeping. Each 3-day recording period mainly included 2 weekdays and 1 weekend day. Participants estimated portion sizes using a food picture booklet. Participants returned the food record to the nurse, who reviewed it with the participant and completed missing or incomplete information. The study nurses who took care of the field work completed an intensive training program arranged by one of the authors (K.Y., MSc in nutrition, authorized nutritionist), and the quality in which the food records were checked was monitored continuously. Food intake data were entered into the computer by two of the authors (C.K-K., majoring in nutrition at the time of the field study, and K.Y.) and processed by the Nutnet software developed at the National Public Health Institute, Helsinki, Finland (20). This software allowed us to input recipes and specific ingredients for analysis. The dietary intake was calculated as the mean of the 6 recording days. Fiber variables included total dietary fiber, analyzed by the enzymatic gravimetric method of Asp et al. (21), water-insoluble dietary fiber (including cellulose, lignin, and water-insoluble noncellulosic polysaccharides), and water-soluble dietary fiber (water-soluble noncellulosic polysaccharides), both of which were analyzed by the method of Englyst (22). The intake of energy and energy-adjusted intake of saturated fatty acids, thiamin, vitamin C, and β-carotene were also calculated (amounts from supplements were included).

After an overnight fast, the subjects underwent a 75-g oral glucose tolerance test. Blood samples for the measurement of glucose and insulin were drawn at −5, 0, 30, and 120 min and, for nonesterified fatty acids (NEFAs), at 0 and 120 min. Plasma glucose was measured with a glucose oxidase method (Beckman Glucose Analyzer II; Beckman Instruments, Fullerton, CA). Serum insulin was measured by radioimmunoassay (Pharmacia, Uppsala, Sweden) with an interassay coefficient of variation <9%. Serum NEFAs were measured by an enzymatic colorimetric method using a commercially available kit (Wako Chemicals, Neuss, Germany). From fasting venous samples, serum triglyceride and total and HDL cholesterol concentrations were measured by enzymatic methods using the Cobas Mira autoanalyzer (Hoffman-La Roche, Basel, Switzerland). Serum HDL cholesterol concentration was measured enzymatically after precipitation of the apolipoprotein B–containing lipoproteins with heparin and manganese chloride. Serum LDL cholesterol concentration was calculated by the Friedewald formula (23) if the serum triglyceride concentration did not exceed 5 mmol/l.

As a measure of insulin resistance we used the homeostasis model assessment (HOMA) insulin resistance index (24). The insulinogenic index, i.e., incremental serum insulin concentration at 30 min during the oral glucose tolerance test divided by the incremental glucose concentration at 30 min [(Ins30 − Ins0)/(Glu30 − Glu0)], was used as the measure of insulin secretion (25). Twelve subjects with a 30-min glucose concentration less than or equal to the fasting glucose concentration were excluded. The insulinogenic index is a surrogate of first-phase insulin release during an intravenous glucose tolerance test (25). Glucose tolerance status at the time of this study was determined according to the 1998 World Health Organization criteria (26).

Body weight and height were measured with the subject in light indoor clothing without shoes. BMI (body weight in kilograms divided by the square of height in meters) was used as the measure of relative body weight. Waist circumference was measured midway between the lowest rib and the iliac crest, and hip circumference over the widest part of the gluteal region. The waist-to-hip ratio was used as the measure of central obesity. Two blood pressure recordings were obtained from the right arm with the subject seated after 30 min of rest. The mean value of the two readings was used.

A structured questionnaire was used to obtain data on length of education and physical activity during the last 12 months (27). Activity levels were changed to metabolic unit values (METs). METs represent an estimate of the relative intensity of activity by describing the amount of energy needed during exercise compared with resting energy expenditure (1 MET is approximately equal to an energy expenditure of 1 kcal [4.2 kJ] · kg body wt−1 · h−1). Physical activity at work was reported according to a seven-point scale ranging from no work and no activity (MET = 1.5) to very heavy manual work (MET = 10.0). Exercise while going to work was classified by tertiles: first tertile represented travel by motor vehicle (MET = 1.5), second by walking (MET = 3.5), and third by bicycle (MET = 5.0). Leisure time exercise received MET values from 2.0 to 12.5 depending on the type and intensity of the activity. The sum of MET values from work, the work trip, and leisure time described the total physical activity of the subject.

Statistical analyses were performed with the software programs BMDP (version 7.1; BMDP Statistical Software, Los Angeles, CA) and SAS (version 8.1; SAS Institute, Cary, NC). A two-sided P < 0.05 was considered statistically significant. Before analyses, variables with skewed distributions were transformed (logarithmic or reciprocal transformation). The intake of dietary fiber and other nutrients was adjusted for total energy according to the residual adjustment method (28). Residual values were used in analyses.

The significance of difference in continuous variables between groups was tested by ANCOVA, and that in categorical variables by χ2 test. Pearson’s partial correlation coefficients were used to test relationships between dietary fiber and other variables after controlling for the effect of age. The associations between fiber variables and measures of glucose metabolism were studied by multiple linear regression analysis. The selection of variables included in the models was based on both correlation analysis and a priori knowledge about factors associated with the outcome variables. As the participants could be relatives, the analyses were performed with the PROC MIXED procedure (SAS/STAT software; SAS Institute, Cary, NC), where the family connection was considered. Dietary, clinical, anthropometric, and demographic variables, except sex, were included in the models as continuous variables.

The median intake of dietary fiber was 21.6 g in men and 17.1 g in women (Table 1). The intake of total fiber, as well as water-insoluble and water-soluble fiber fractions, inversely correlated with BMI and measures of insulin resistance in both sexes (Table 2). An inverse association between fiber variables and waist-to-hip ratio was observed in men, while in women, fiber variables were inversely related to serum triglycerides and 2-h serum NEFAs. Fiber intake was unrelated to insulin secretion and 2-h plasma glucose concentrations. However, in men, total and water-insoluble fiber intake showed a weak inverse association with the fasting plasma glucose concentration.

Table 3 presents multiple linear regression models with the HOMA insulin resistance index as the dependent variable. Of the demographic, clinical, and dietary variables, sex and those that showed a significant association with the dependent variable in the univariate model (model 1) were included in the multivariate model (model 2). When analyzing men and women together, all fiber variables remained inversely related to insulin resistance (Table 3). When the analyses were performed separately for men and women, fiber variables were not significantly related to insulin resistance (regression coefficients between −0.09 and −0.14, P between 0.14 and 0.46).

Elevated NEFA concentrations have been associated with insulin resistance and deterioration of glucose tolerance (29). We had data on serum NEFA concentrations for 524 subjects. In the univariate model (adjusted for sex and age), both fasting and 2-h serum NEFAs were directly associated with HOMA insulin resistance: 0.22 (0.06) and 0.40 (0.06) [regression coefficients (SE)], P = 0.0002 and P < 0.0001, respectively. Therefore, we reran the multivariate models in Table 3 and included, as an additional independent variable, either fasting or 2-h serum NEFA concentration. In these models, neither fasting nor 2-h serum NEFA was a significant contributor (P > 0.14) and the inverse association of fiber variables with insulin resistance remained unchanged. However, as 2-h serum NEFA and triglyceride concentrations were highly correlated with each other (r = 0.54, P < 0.001) and should therefore not be included simultaneously in a model, we also performed the multivariate models of Table 3 to exclude serum triglycerides but include 2-h serum NEFA as an independent variable. In these models, 2-h serum NEFA turned out to be a significant independent contributor: 0.13 (0.06), P < 0.02 [regression coefficient (SE)], but still had no effect on the inverse association between fiber variables and insulin resistance.

Although in the correlation analysis (Table 2) total and water-insoluble fiber were inversely associated with the fasting plasma glucose concentration in male subjects, in the linear regression models, fiber variables were unrelated to this outcome variable (data not shown).

The present results show that the dietary intake of total fiber as well as water-insoluble and water-soluble fiber was inversely related to insulin resistance, as estimated by HOMA and reflected in fasting serum insulin levels in this high-risk population. The associations were independent of sex, age, physical activity, BMI, waist-to-hip ratio, systolic blood pressure, and serum triglyceride, HDL cholesterol, and NEFA concentrations. On the other hand, the fiber intake was unrelated to post–glucose load insulin secretion and glucose concentrations. The lack of an association between insulin secretion and fiber intake does not, however, indicate an inconsistency with the finding of a relation between insulin resistance and fiber intake since the insulinogenic index we used estimates only one aspect of insulin secretion (representing a surrogate of first-phase insulin release during an intravenous glucose tolerance test) and is not correlated with insulin resistance (25).

That dietary fiber and insulin resistance are related to each other has been observed earlier. The cross-sectional analysis in the CARDIA (Coronary Artery Risk Development in Young Adults) study among 18- to 30-year-old black and white subjects found an inverse age- and BMI-adjusted association between fiber and fasting serum insulin among white women (3), and, in the 10-year follow-up, fiber intake predicted insulin levels (30). Among normoglycemic lean and obese subjects, dietary fiber intake was positively associated with insulin sensitivity and inversely with fasting glucose concentrations (4); fiber intake accounted for 18% of the variance in insulin sensitivity, but the significance of the association was removed after adjustment for BMI. In a cross-sectional study of elderly nondiabetic men, the intake of total dietary fiber was inversely associated with insulin levels and fasting C-peptide (5). The effect of dietary fiber on insulin levels, when comparing lowest and highest quartiles, was assessed to be of similar magnitude as physical activity. In the ARIC (Atherosclerosis Risk in Communities) study (6) population of nondiabetic middle-aged subjects, an inverse association between dietary fiber and fasting serum insulin was observed among women. A 7-g/day higher intake of fiber was associated with a 2.9% lower fasting insulin level. Thus, both our study and earlier findings suggest that fiber intake and insulin resistance are inversely related.

In accordance with our data, previous cross-sectional studies (8,31,32) have not found an association between fiber intake and glucose tolerance. Among middle-aged and elderly nondiabetic men, total dietary fiber was not associated with fasting glucose or with the incremental area under the glucose curve (IAUC) (31). The intake of pectin, a water-soluble fraction of fiber, however, was inversely associated with the IAUC. The reduced pectin intake during a 10-year follow-up was also inversely associated with the IAUC (31). In a cross-sectional analysis in the San Luis Valley Diabetes Study population, dietary fiber did not have an effect on glucose tolerance independent of fat intake (8). The subsequent detailed analysis of dietary fiber and glucose metabolism in that population found that 1) the recalled intake of dietary fiber before the diagnosis of type 2 diabetes was directly related to the disease, 2) current fiber intake and fasting plasma insulin concentration were inversely associated among subjects without a history of diabetes (fiber explaining <1% of the variation in fasting insulin), and 3) the intake of dietary fiber was not associated with newly diagnosed diabetes (32). The authors concluded that the weak and inconsistent findings did not support the hypothesis that increasing dietary fiber intake would reduce occurrence of diabetes. However, the inverse association between dietary fiber and fasting insulin concentration was confirmed in a longitudinal analysis of the population (33). The association was strongest in lean subjects.

Three studies have assessed associations between fiber intake and diabetes in high-risk populations: Among the Nauruan population, fiber intake was unrelated to the prevalence and incidence of type 2 diabetes, although the small number of subjects with newly diagnosed diabetes precluded firm conclusions on future diabetes risk (10). A study in Papua New Guinea (11) found a weak direct association between dietary fiber and newly diagnosed type 2 diabetes. In contrast, among a remote aboriginal community in Ontario, a high intake of dietary fiber was found to be associated with reduced risk of newly diagnosed diabetes (34).

Earlier prospective studies investigating a relationship between fiber and diabetes risk did not show a role for fiber. In normoglycemic elderly men and women, dietary fiber was not associated with the 4-year incidence of glucose intolerance (7). However, future cases of glucose intolerance had a lower intake of legumes, which have a high content of water-soluble fibers. In the 6-year follow-up of the U.S. Nurses’ Health Study, the dietary fiber intake, whether evaluated as total intake or as contributions from fruits, vegetables, and cereals, was not related to the risk of type 2 diabetes (9). In the 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study in men, a borderline significant inverse association between past total fiber intake and 2-h glucose level was observed (12). However, later studies have yielded more promising results: in another 6-year follow-up in U.S. nurses (14), total dietary fiber intake and especially cereal fiber (mostly insoluble) were inversely related to the risk of type 2 diabetes, although fruit and vegetable fiber (mostly soluble) showed no association. In the 6-year follow-up of U.S. male health professionals (13), only cereal dietary fiber intake, but not total or fruit and vegetable fiber, was inversely associated with the risk of type 2 diabetes. In a cohort of older women in a 6-year follow-up, the intake of total and insoluble fiber, but not of soluble fiber, was inversely associated with the incidence of diabetes (17). Women in the highest quintile of fiber intake (median 27 g/day) had a 22% lower risk of developing diabetes than women in the lowest quintile (13 g/day). Thus, recent findings from prospective cohort studies suggest that a high intake of dietary fiber, and perhaps especially insoluble fiber, is associated with reduced diabetes risk.

Mechanisms linking dietary fiber with glucose metabolism are unclear but there are likely many. First, the effects of dietary fiber on insulin sensitivity might be mediated by obesity (4). Dietary fiber promotes food intake control (35). The physical and chemical properties of fiber aid in early signals of satiation and enhanced or prolonged signals of satiety, thus reducing total energy intake and adiposity (2,35). Second, the beneficial effects of fiber on glucose metabolism may be the result of delayed gastric emptying rate and slowed digestion and absorption of food, thereby reducing the rate of glucose absorption and plasma insulin levels (2,31). This effect has been attributed primarily to soluble fiber, which creates a gel-like substance in the stomach (15,16). Furthermore, fiber regulates several metabolic hormones that affect glucose metabolism (17,33). There is evidence that improvements in glucose homeostasis observed through the long-term high intake of dietary fiber may be explained by increased intestinal proglucagon gene expression (36,37). Proglucagon encodes several proglucagon-derived peptides known to modulate intestinal absorption capacity and pancreatic insulin secretion (37). Finally, a concomitant intake of other dietary components that affect glucose metabolism and are highly correlated with fiber, e.g., chromium, magnesium, and manganese, may contribute to these beneficial effects. Bakker et al. (38) found that part of the association between fiber intake and glucose tolerance was attributable to concomitant thiamin intake.

To conclude, we observed an independent positive association between the dietary intake of total as well as water-insoluble and water-soluble fiber and enhanced insulin sensitivity in this population at high risk for type 2 diabetes. When gathering the data, special emphasis was placed to receive representative and accurate dietary data. In addition, we were able to adjust for relevant dietary and clinical factors in the analysis. The cross-sectional nature of the study, however, precludes interpreting the association as a causal one. Nevertheless, results support earlier evidence, suggesting a role for dietary fiber in insulin sensitivity and, therefore, in prevention of type 2 diabetes (39,40).

Table 1—

Characteristics and intake of dietary fiber in 552 male and female nondiabetic relatives of subjects with type 2 diabetes

MenWomen
n 248 304 
Age (years) 50.1 (10.2) 51.4 (10.4) 
Length of education (years)   
  6–9 (basic) 142 (57) 151 (50) 
  >9 (secondary or higher) 106 (43) 153 (50) 
Physical activity (MET/day) 10.3 (3.8) 8.8 (3.2) 
BMI (kg/m226.5 (3.0) 26.3 (4.0) 
Waist-to-hip ratio 0.95 (0.06) 0.83 (0.06) 
Systolic blood pressure (mmHg) 129 (15) 129 (17) 
Diastolic blood pressure (mmHg) 80 (10) 80 (9) 
Fasting plasma glucose (mmol/l) 5.5 (0.6) 5.4 (0.6) 
Fasting serum insulin (pmol/l) 48 (27) 47 (25) 
Serum triglycerides (mmol/l) 1.42 (0.78)* 1.24 (0.61) 
Serum total cholesterol (mmol/l) 5.63 (0.93)* 5.67 (1.07) 
Serum LDL cholesterol (mmol/l) 3.78 (0.86) 3.71 (0.98)§ 
Serum HDL cholesterol (mmol/l) 1.21 (0.27) 1.40 (0.32) 
Fasting serum NEFAs (μmol/l) 451 (168) 533 (182)# 
2-h serum NEFAs (μmol/l) 167 (57) 149 (50)# 
Glucose tolerance status**   
  Normal glucose tolerance 191 (77) 241 (79) 
  Impaired fasting glucose 33 (13) 33 (11) 
  Impaired glucose tolerance 24 (10) 30 (10) 
Energy intake (kcal) 2,249 (1,883–2,721) 1,604 (1,377–1,856) 
Dietary intake (g)   
  Total dietary fiber†† 21.6 (17.6–25.7) 17.1 (14.2–20.6) 
  Water-insoluble dietary fiber‡‡ 15.3 (12.4–18.5) 11.8 (9.8–14.1) 
  Water-soluble dietary fiber§§ 4.7 (3.9–5.6) 4.0 (3.3–4.8) 
MenWomen
n 248 304 
Age (years) 50.1 (10.2) 51.4 (10.4) 
Length of education (years)   
  6–9 (basic) 142 (57) 151 (50) 
  >9 (secondary or higher) 106 (43) 153 (50) 
Physical activity (MET/day) 10.3 (3.8) 8.8 (3.2) 
BMI (kg/m226.5 (3.0) 26.3 (4.0) 
Waist-to-hip ratio 0.95 (0.06) 0.83 (0.06) 
Systolic blood pressure (mmHg) 129 (15) 129 (17) 
Diastolic blood pressure (mmHg) 80 (10) 80 (9) 
Fasting plasma glucose (mmol/l) 5.5 (0.6) 5.4 (0.6) 
Fasting serum insulin (pmol/l) 48 (27) 47 (25) 
Serum triglycerides (mmol/l) 1.42 (0.78)* 1.24 (0.61) 
Serum total cholesterol (mmol/l) 5.63 (0.93)* 5.67 (1.07) 
Serum LDL cholesterol (mmol/l) 3.78 (0.86) 3.71 (0.98)§ 
Serum HDL cholesterol (mmol/l) 1.21 (0.27) 1.40 (0.32) 
Fasting serum NEFAs (μmol/l) 451 (168) 533 (182)# 
2-h serum NEFAs (μmol/l) 167 (57) 149 (50)# 
Glucose tolerance status**   
  Normal glucose tolerance 191 (77) 241 (79) 
  Impaired fasting glucose 33 (13) 33 (11) 
  Impaired glucose tolerance 24 (10) 30 (10) 
Energy intake (kcal) 2,249 (1,883–2,721) 1,604 (1,377–1,856) 
Dietary intake (g)   
  Total dietary fiber†† 21.6 (17.6–25.7) 17.1 (14.2–20.6) 
  Water-insoluble dietary fiber‡‡ 15.3 (12.4–18.5) 11.8 (9.8–14.1) 
  Water-soluble dietary fiber§§ 4.7 (3.9–5.6) 4.0 (3.3–4.8) 

Data are n (%) for categorical variables, median (25th–75th percentile) for dietary variables, and otherwise mean (SD).

*

n = 246;

n = 302;

n = 244;

§

n = 301;

n = 245;

n = 238;

#

n = 286;

**

glucose tolerance status according to 1998 WHO criteria (26);

††

because different methods were used to analyze total fiber and fiber fractions, the sum of the fractions is not the same as the amount of total fiber;

‡‡

water-insoluble dietary fiber consists of cellulose, lignin, and water-insoluble noncellulosic polysaccharides;

§§

water-soluble noncellulosic polysaccharides.

Table 2—

Pearson’s partial correlation coefficients (adjusted for age) between energy-adjusted dietary fiber intake and demographic and clinical characteristics in 248 male and 304 female nondiabetic relatives of subjects with type 2 diabetes

Men (n = 248)
Women (n = 304)
Total fiberWater-insoluble fiberWater-soluble fiberTotal fiberWater-insoluble fiberWater-soluble fiber
Length of education 0.04 (0.52) 0.03 (0.62) 0.03 (0.61) 0.11 (0.056) 0.10 (0.096) 0.16 (0.005) 
Physical activity 0.10 (0.12) 0.09 (0.15) 0.13 (0.043) 0.06 (0.31) 0.04 (0.44) 0.05 (0.41) 
BMI −0.15 (0.019) −0.14 (0.033) −0.14 (0.033) −0.14 (0.012) −0.15 (0.009) −0.11 (0.058) 
Waist-to-hip ratio −0.18 (0.004) −0.15 (0.017) −0.21 (0.001) −0.06 (0.30) −0.05 (0.36) −0.06 (0.30) 
Systolic blood pressure −0.05 (0.47) −0.06 (0.38) −0.07 (0.26) −0.08 (0.18) −0.07 (0.23) −0.03 (0.55) 
Diastolic blood pressure −0.06 (0.32) −0.06 (0.33) −0.08 (0.21) −0.08 (0.19) −0.08 (0.14) −0.02 (0.70) 
Serum triglycerides −0.10 (0.11)* −0.10 (0.10)* −0.07 (0.31)* −0.16 (0.005) −0.15 (0.009) −0.16 (0.006) 
Serum total cholesterol −0.01 (0.93)* 0.01 (0.91)* 0.01 (0.83)* −0.06 (0.29) −0.04 (0.52) −0.10 (0.075) 
Serum LDL cholesterol 0.01 (0.94) 0.02 (0.80) 0.02 (0.76) −0.06 (0.33)§ −0.04 (0.52)§ −0.10 (0.078)§ 
Serum HDL cholesterol 0.09 (0.18) 0.09 (0.14) 0.05 (0.41) 0.09 (0.13) 0.09 (0.12) 0.08 (0.15) 
Fasting serum NEFAs −0.03 (0.70) −0.04 (0.54) −0.06 (0.37) −0.12 (0.050)# −0.10 (0.10)# −0.07 (0.24)# 
2-h serum NEFAs −0.10 (0.11) −0.11 (0.086) −0.09 (0.19) −0.18 (0.002)# −0.18 (0.003)# −0.13 (0.028)# 
Fasting plasma glucose −0.13 (0.037) −0.13 (0.034) −0.10 (0.10) 0.02 (0.70) 0.03 (0.63) 0.03 (0.62) 
2-h plasma glucose 0.01 (0.84) 0.004 (0.95) 0.02 (0.75) 0.01 (0.93) 0.003 (0.96) −0.005 (0.93) 
Fasting serum insulin −0.22 (0.0004) −0.21 (0.001) −0.20 (0.001) −0.18 (0.002) −0.17 (0.003) −0.15 (0.009) 
HOMA isulin resistance index −0.24 (0.0002) −0.22 (0.0004) −0.21 (0.001) −0.16 (0.006) −0.15 (0.010) −0.13 (0.025) 
Insulin secretion during OGTT (Ins30 − Ins0) / (Glu30 − Glu0−0.09 (0.19)** −0.08 (0.21)** −0.06 (0.33)** −0.05 (0.36)†† −0.05 (0.38)†† −0.07 (0.23)†† 
Men (n = 248)
Women (n = 304)
Total fiberWater-insoluble fiberWater-soluble fiberTotal fiberWater-insoluble fiberWater-soluble fiber
Length of education 0.04 (0.52) 0.03 (0.62) 0.03 (0.61) 0.11 (0.056) 0.10 (0.096) 0.16 (0.005) 
Physical activity 0.10 (0.12) 0.09 (0.15) 0.13 (0.043) 0.06 (0.31) 0.04 (0.44) 0.05 (0.41) 
BMI −0.15 (0.019) −0.14 (0.033) −0.14 (0.033) −0.14 (0.012) −0.15 (0.009) −0.11 (0.058) 
Waist-to-hip ratio −0.18 (0.004) −0.15 (0.017) −0.21 (0.001) −0.06 (0.30) −0.05 (0.36) −0.06 (0.30) 
Systolic blood pressure −0.05 (0.47) −0.06 (0.38) −0.07 (0.26) −0.08 (0.18) −0.07 (0.23) −0.03 (0.55) 
Diastolic blood pressure −0.06 (0.32) −0.06 (0.33) −0.08 (0.21) −0.08 (0.19) −0.08 (0.14) −0.02 (0.70) 
Serum triglycerides −0.10 (0.11)* −0.10 (0.10)* −0.07 (0.31)* −0.16 (0.005) −0.15 (0.009) −0.16 (0.006) 
Serum total cholesterol −0.01 (0.93)* 0.01 (0.91)* 0.01 (0.83)* −0.06 (0.29) −0.04 (0.52) −0.10 (0.075) 
Serum LDL cholesterol 0.01 (0.94) 0.02 (0.80) 0.02 (0.76) −0.06 (0.33)§ −0.04 (0.52)§ −0.10 (0.078)§ 
Serum HDL cholesterol 0.09 (0.18) 0.09 (0.14) 0.05 (0.41) 0.09 (0.13) 0.09 (0.12) 0.08 (0.15) 
Fasting serum NEFAs −0.03 (0.70) −0.04 (0.54) −0.06 (0.37) −0.12 (0.050)# −0.10 (0.10)# −0.07 (0.24)# 
2-h serum NEFAs −0.10 (0.11) −0.11 (0.086) −0.09 (0.19) −0.18 (0.002)# −0.18 (0.003)# −0.13 (0.028)# 
Fasting plasma glucose −0.13 (0.037) −0.13 (0.034) −0.10 (0.10) 0.02 (0.70) 0.03 (0.63) 0.03 (0.62) 
2-h plasma glucose 0.01 (0.84) 0.004 (0.95) 0.02 (0.75) 0.01 (0.93) 0.003 (0.96) −0.005 (0.93) 
Fasting serum insulin −0.22 (0.0004) −0.21 (0.001) −0.20 (0.001) −0.18 (0.002) −0.17 (0.003) −0.15 (0.009) 
HOMA isulin resistance index −0.24 (0.0002) −0.22 (0.0004) −0.21 (0.001) −0.16 (0.006) −0.15 (0.010) −0.13 (0.025) 
Insulin secretion during OGTT (Ins30 − Ins0) / (Glu30 − Glu0−0.09 (0.19)** −0.08 (0.21)** −0.06 (0.33)** −0.05 (0.36)†† −0.05 (0.38)†† −0.07 (0.23)†† 

Data are r (P);

*

n = 246;

n = 302;

n = 244;

§

n = 301;

n = 245;

n = 238;

#

n = 286;

**

n = 243;

††

n = 297; OGTT, oral glucose tolerance test.

Table 3—

Multiple linear regression models with the HOMA insulin resistance index as dependent variable and fiber and other dietary and clinical variables as independent variables in nondiabetic relatives of subjects with type 2 diabetes

Model 1 (n = 552)
Model 2a (n = 546)
Model 2b (n = 546)
Model 2c (n = 546)
Regression coefficient (SE)PRegression coefficient (SE)PRegression coefficient (SE)PRegression coefficient (SE)P
Intercept — — −5.27 (0.81) <0.0001 −5.25 (0.81) <0.0001 −5.30 (0.81) <0.0001 
Sex −0.05 (0.04)* 0.20 0.20 (0.05) <0.0001 0.20 (0.05) <0.0001 0.21 (0.05) <0.0001 
Age 0.01 (0.002) <0.0001 −0.004 (0.002) 0.058 −0.004 (0.002) 0.053 −0.004 (0.002) 0.032 
Length of education −0.11 (0.09) 0.23 — — — — — — 
Physical activity −0.26 (0.06) <0.0001 −0.20 (0.05) <0.0001 −0.20 (0.05) <0.0001 −0.20 (0.05) <0.0001 
BMI 1.81 (0.14) <0.0001 0.91 (0.15) <0.0001 0.91 (0.15) <0.0001 0.93 (0.15) <0.0001 
Waist-to-hip ratio 3.06 (0.28) <0.0001 1.38 (0.28) <0.0001 1.39 (0.28) <0.0001 1.36 (0.28) <0.0001 
Systolic blood pressure 1.28 (0.19) <0.0001 0.69 (0.16) <0.0001 0.69 (0.16) <0.0001 0.69 (0.16) <0.0001 
Serum triglycerides 0.49 (0.04) <0.0001 0.23 (0.05) <0.0001 0.23 (0.05) <0.0001 0.23 (0.05) <0.0001 
Serum HDL cholesterol −0.74 (0.09)§ <0.0001 −0.17 (0.09) 0.045 −0.17 (0.09) 0.047 −0.18 (0.09) 0.043 
Saturated fatty acids 0.07 (0.11) 0.51 — — — — — — 
Thiamin −0.002 (0.07) 0.97 — — — — — — 
Vitamin C −0.05 (0.03) 0.10 — — — — — — 
β-Carotene −0.04 (0.03) 0.13 — — — — — — 
Total fiber −0.38 (0.08) <0.0001 −0.17 (0.07) 0.012 — — — — 
Water-insoluble fiber −0.35 (0.08) <0.0001 — — −0.15 (0.07) 0.024 — — 
Water-soluble fiber −0.33 (0.09) 0.0002 — — — — −0.14 (0.07) 0.049 
Model 1 (n = 552)
Model 2a (n = 546)
Model 2b (n = 546)
Model 2c (n = 546)
Regression coefficient (SE)PRegression coefficient (SE)PRegression coefficient (SE)PRegression coefficient (SE)P
Intercept — — −5.27 (0.81) <0.0001 −5.25 (0.81) <0.0001 −5.30 (0.81) <0.0001 
Sex −0.05 (0.04)* 0.20 0.20 (0.05) <0.0001 0.20 (0.05) <0.0001 0.21 (0.05) <0.0001 
Age 0.01 (0.002) <0.0001 −0.004 (0.002) 0.058 −0.004 (0.002) 0.053 −0.004 (0.002) 0.032 
Length of education −0.11 (0.09) 0.23 — — — — — — 
Physical activity −0.26 (0.06) <0.0001 −0.20 (0.05) <0.0001 −0.20 (0.05) <0.0001 −0.20 (0.05) <0.0001 
BMI 1.81 (0.14) <0.0001 0.91 (0.15) <0.0001 0.91 (0.15) <0.0001 0.93 (0.15) <0.0001 
Waist-to-hip ratio 3.06 (0.28) <0.0001 1.38 (0.28) <0.0001 1.39 (0.28) <0.0001 1.36 (0.28) <0.0001 
Systolic blood pressure 1.28 (0.19) <0.0001 0.69 (0.16) <0.0001 0.69 (0.16) <0.0001 0.69 (0.16) <0.0001 
Serum triglycerides 0.49 (0.04) <0.0001 0.23 (0.05) <0.0001 0.23 (0.05) <0.0001 0.23 (0.05) <0.0001 
Serum HDL cholesterol −0.74 (0.09)§ <0.0001 −0.17 (0.09) 0.045 −0.17 (0.09) 0.047 −0.18 (0.09) 0.043 
Saturated fatty acids 0.07 (0.11) 0.51 — — — — — — 
Thiamin −0.002 (0.07) 0.97 — — — — — — 
Vitamin C −0.05 (0.03) 0.10 — — — — — — 
β-Carotene −0.04 (0.03) 0.13 — — — — — — 
Total fiber −0.38 (0.08) <0.0001 −0.17 (0.07) 0.012 — — — — 
Water-insoluble fiber −0.35 (0.08) <0.0001 — — −0.15 (0.07) 0.024 — — 
Water-soluble fiber −0.33 (0.09) 0.0002 — — — — −0.14 (0.07) 0.049 

Model 1: univariate models (adjusted for sex and age) for each independent variable; Model 2: all variables simultaneously in the model;

*

adjusted for age;

adjusted for sex (men = 1, women = 2);

n = 548;

§

n = 547.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The Botnia Study is financially supported by the Sigrid Jusélius Foundation, the Academy of Finland, the Folkhälsan Foundation, the Finnish Diabetes Research Foundation, a European Community grant (GIFT-QLRT-1999-00546), and the JDF-Wallenberg Center of Excellence. The Botnia Dietary Study is financially supported by the Leo and Regina Wainstein Foundation, the Finnish Cultural Foundation, the Yrjö Jahnsson Foundation, the Juho Vainio Foundation, the Oskar Öflund Foundation, and the Otto A. Malm Foundation.

We thank the Botnia research team for their vital assistance throughout the project and the families for their participation. We are also grateful for the skillful technical assistance of the Helsinki Botnia research laboratory and the Core Lipid Laboratory at Helsinki University Central Hospital.

1
Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL: High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults.
Am J Clin Nutr
52
:
524
–528,
1990
2
McIntosh M, Miller C: A diet containing food rich in soluble and insoluble fiber improves glycemic control and reduces hyperlipidemia among patients with type 2 diabetes mellitus.
Nutr Rev
59
:
52
–55,
2001
3
Manolio TA, Savage PJ, Burke GL, Hilner JE, Liu K, Orchard TJ, Sidney S, Oberman A: Correlates of fasting insulin levels in young adults: the CARDIA study.
J Clin Epidemiol
44
:
571
–578,
1991
4
Lovejoy J, DiGirolamo M: Habitual dietary intake and insulin sensitivity in lean and obese adults.
Am J Clin Nutr
55
:
1174
–1179,
1992
5
Feskens EJM, Loeber JG, Kromhout D: Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study.
Am J Epidemiol
140
:
350
–360,
1994
6
Vitelli LL, Folsom AR, Shahar E, Winkhart SP, Shimakawa T, Stevens J, Duncan BB, Chambless LE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Association of dietary composition with fasting serum insulin level: the ARIC Study.
Nutr Metab Cardiovasc Dis
6
:
194
–202,
1996
7
Feskens EJM, Bowles CH, Kromhout D: Carbohydrate intake and body mass index in relation to the risk of glucose intolerance in an elderly population.
Am J Clin Nutr
54
:
136
–140,
1991
8
Marshall JA, Hamman RF, Baxter J: High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study.
Am J Epidemiol
134
:
590
–603,
1991
9
Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE: Diet and risk of clinical diabetes in women.
Am J Clin Nutr
55
:
1018
–1023,
1992
10
Hodge AM, Dowse GK, Zimmet PZ: Diet does not predict incidence or prevalence of non-insulin-dependent diabetes in Nauruans.
Asia Pacific J Clin Nutr
2
:
35
–41,
1993
11
Hodge AM, Montgomery J, Dowse GK, Mavo B, Watt T, Zimmet PZ: A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea.
Diabetes Care
19
:
457
–462,
1996
12
Feskens EJM, Virtanen SM, Räsänen L, Tuomilehto J, Stengård J, Pekkanen J, Nissinen A, Kromhout D: Dietary factors determining diabetes and impaired glucose tolerance: a 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study.
Diabetes Care
18
:
1104
–1112,
1995
13
Salmerón J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of NIDDM in men.
Diabetes Care
20
:
545
–550,
1997
14
Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women.
JAMA
277
:
472
–477,
1997
15
Jenkins DJA, Axelsen M, Kendall CWC, Augustin LSA, Vuksan V, Smith U: Dietary fibre, lente carbohydrates and the insulin-resistant diseases.
Br J Nutr
83 (Suppl. 1)
:
S157
–S163,
2000
16
Sierra M, Garcia JJ, Fernández N, Diez MJ, Calle AP, Sahagún AM, the Farmafibra Group: Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects.
Eur J Clin Nutr
55
:
235
–243,
2001
17
Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women.
Am J Clin Nutr
71
:
921
–930,
2000
18
Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissén M, Ehrnström B-O, Forsén B, Isomaa B, Snickars B, Taskinen M-R, the Botnia Study: Metabolic consequences of a family history of NIDDM (the Botnia Study).
Diabetes
45
:
1585
–1593,
1996
19
World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org.,
1985
(Tech. Rep. Ser., no. 727)
20
Ovaskainen M-L, Valsta LM, Lauronen J: The compilation of food analysis values as a database for dietary studies: the Finnish experience.
Food Chem
57
:
133
–136,
1996
21
Asp N-G, Johansson C-G, Hallmer H, Siljeström M: Rapid enzymatic assay of insoluble and soluble dietary fiber.
J Agric Food Chem
31
:
476
–482,
1983
22
Englyst H: Determination of carbohydrate and its composition in plant materials. In
The Analysis of Dietary Fibre in Food
. James WPT, Theander O, Eds. New York, Marcel Decker,
1981
, p.
71
–93
23
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
Clin Chem
18
:
499
–502,
1972
24
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia
28
:
412
–419,
1985
25
Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.
Diabet Med
11
:
286
–292,
1994
26
Alberti KGMM, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation.
Diabet Med
15
:
539
–553,
1998
27
Mälkiä E, Impivaara O, Maatela J, Aromaa A, Heliövaara M, Knekt P:
Suomalaisten aikuisten fyysinen aktiivisuus
[Physical activity of Finnish adults]. In Finnish, English summary. Turku, Finland, Publications of the Social Insurance Institution,
1988
, p.
16
, 96–110
28
Willett W, Stampfer MJ: Total energy intake: implications for epidemiologic analyses.
Am J Epidemiol
124
:
17
–27,
1986
29
Charles MA, Eschwège E, Thibult N, Claude J-R, Warnet J-M, Rosselin GE, Girard J, Balkau B: The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.
Diabetologia
40
:
1101
–1106,
1997
30
Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, Jacobs DR Jr: Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
JAMA
282
:
1539
–1546,
1999
31
Feskens EJM, Kromhout D: Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen Study.
Int J Epidemiol
19
:
953
–959,
1990
32
Marshall JA, Weiss NS, Hamman RF: The role of dietary fiber in the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study.
Ann Epidemiol
3
:
18
–26,
1993
33
Marshall JA, Bessesen DH, Hamman RF: High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study.
Diabetologia
40
:
430
–438,
1997
34
Wolever TMS, Hamad S, Gittelsohn J, Gao J, Hanley AJG, Harris SB, Zinman B: Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community.
Am J Clin Nutr
66
:
1470
–1474,
1997
35
Burton-Freeman B: Dietary fiber and energy regulation.
J Nutr
130
:
272S
–275S,
2000
36
Reimer RA, Thomson ABR, Rajotte RV, Basu TK, Ooraikul B, McBurney MI: A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats.
J Nutr
127
:
1923
–1928,
1997
37
Massimino SP, McBurney MI, Field CJ, Thomson ABR, Keelan M, Hayek MG, Sunvold GD: Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs.
J Nutr
128
:
1786
–1793,
1998
38
Bakker SJL, Hoogeveen EK, Nijpels G, Kostense PJ, Dekker JM, Gans ROB, Heine RJ: The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: the Hoorn Study.
Diabetologia
41
:
1168
–1175,
1998
39
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med
344
:
1343
–1350,
2001
40
The Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
N Engl J Med
346
:
393
–403,
2002